COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien UK Award for Best digital health solution for AI-Immunology™.
GEORGE TOWN, Cayman Islands, June 12, 2026 (GLOBE NEWSWIRE) -- Toobit, the award-winning global cryptocurrency exchange, today upgrades its copy trading platform, expanding its zero-slippage capability.
SINGAPORE, June 12, 2026 /PRNewswire/ -- Food remains a compelling reason for travel, drawing explorers to new destinations with the promise of authentic flavors...
SHENZHEN, China, June 12, 2026 /PRNewswire/ -- Tencent Cloud, the cloud business of global leading technology company Tencent, today announced it has secured the...
BURLINGAME, Calif., June 11, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and...
HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab...
Nordstrom, Inc. and Master Perfumer Honorine Blanc Receive Industry's Top Honors-Ceremony Pays Tribute to Legends Lost - Giorgio Armani and Valentino GaravaniNEW YORK, June 11, 2026 /PRNewswire/...
The Emerging Techbio Company Appoints Dr. John Mumm as CSO Alongside Head of Platform Dr. Yambazi Banda to Decode the Molecular Underpinnings of Neuroimmune...
Total number of shares and voting rights in the share capital as of May 31, 2026 (Articles L. 233-8 (II) of the French Commercial Code and 223-16 of the General Regulations of the French Financial Markets Authority)